Free
Clinical and Epidemiologic Research  |   July 2012
Prevalence and Associated Risk Factors of Myopic Maculopathy in Elderly Chinese: The Shihpai Eye Study
Author Affiliations & Notes
  • Shih-Jen Chen
    From the Department of Ophthalmology, Taipei Veterans General Hospital, Taipei, Taiwan;
    Department of Ophthalmology, School of Medicine; the
  • Ching-Yu Cheng
    From the Department of Ophthalmology, Taipei Veterans General Hospital, Taipei, Taiwan;
    Department of Ophthalmology, Yong Loo Lin School of Medicine; the
  • An-Fei Li
    From the Department of Ophthalmology, Taipei Veterans General Hospital, Taipei, Taiwan;
    Department of Ophthalmology, School of Medicine; the
  • Kai-Ling Peng
    From the Department of Ophthalmology, Taipei Veterans General Hospital, Taipei, Taiwan;
  • Pesus Chou
    Community Medicine Research Center and Institute of Public Health; the
  • Shih-Hwa Chiou
    From the Department of Ophthalmology, Taipei Veterans General Hospital, Taipei, Taiwan;
    Institute of Pharmacology; the
    Institute of Clinical Medicine, National Yang-Ming University, Taipei, Taiwan; the
  • Wen-Ming Hsu
    Department of Ophthalmology, Shuang-Ho Hospital,
    Department of Ophthalmology, School of Medicine, Taipei Medical University, Taipei, Taiwan; the
  • Corresponding author: Shih-Jen Chen, Department of Ophthalmology, Taipei Veterans General Hospital, 201, Shih-Pai Road, 112, Taipei, Taiwan. [email protected]  
Investigative Ophthalmology & Visual Science July 2012, Vol.53, 4868-4873. doi:https://doi.org/10.1167/iovs.12-9919
  • Views
  • PDF
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Shih-Jen Chen, Ching-Yu Cheng, An-Fei Li, Kai-Ling Peng, Pesus Chou, Shih-Hwa Chiou, Wen-Ming Hsu; Prevalence and Associated Risk Factors of Myopic Maculopathy in Elderly Chinese: The Shihpai Eye Study. Invest. Ophthalmol. Vis. Sci. 2012;53(8):4868-4873. https://doi.org/10.1167/iovs.12-9919.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose.: To assess the prevalence and associated risk factors of myopic maculopathy in an elderly Chinese population in Taiwan.

Methods.: Population-based, cross-sectional study. A total of 1361 Chinese aged 65 years or older residing in Shihpai, Taipei, Taiwan, underwent a detailed ophthalmic examination. Of the 1361 participants, 1058 subjects had at least one gradable fundus photograph and were recruited for analysis. High myopia was defined as spherical equivalent of less than −6.0 diopter (D) in the phakic eyes or axial length greater than 26.5 mm in pseudophakic or aphakic eyes. Myopic maculopathy was defined as the appearance of lacquer cracks, focal area of deep choroidal atrophy and macular choroidal neovascularization, or geographic atrophy in the presence of high myopia.

Results.: The prevalence of high myopia was 4.2% (44/1058). Signs of myopic maculopathy were present in 32 (72.7%) of the 44 high myopics, representing a prevalence of 3.0% (95% confidence interval, 2.0%–4.0%). Subjects with high myopia with myopic maculopathy had higher systolic blood pressure than those without maculopathy (146.4 ± 16.2 mm Hg vs. 127.0 ± 15.9 mm Hg, P = 0.001), and the difference persisted (P = 0.018) after adjustment for age, sex, smoking, body mass index, diastolic blood pressure, educational levels, alcohol drinking, and histories of diabetes or taking anti-hypertension medication. Of the 65 high myopic eyes, eyes with maculopathy had a greater myopic degree (−12.8 ± 5.1 D vs. −7.6 ± 1.5 D, P = 0.001) and poorer corrected visual acuity (logMAR 0.72 ± 0.6 vs. 0.27 ± 0.2, P = 0.001) than those without.

Conclusions.: The prevalence of high myopia and myopic maculopathy in this elderly Chinese population group was high. Of the major risk factors examined, high systolic blood pressure may be associated with myopic maculopathy.

Introduction
Myopia is common and its prevalence is increasing worldwide. 16 High myopia, defined as spherical equivalent of less than −6 diopters (D) or axial length greater than 26.5 mm, 7,8 constitutes approximately 11% to 14% of cases of myopia. 1,911 Of the adolescent myopic population, high myopia may account for up to 20%. 2 High myopia is more common in Asians, compared with European-derived populations. 12 However, recent surveys showed that in the past 30 years, the prevalence of high myopia has increased 8-fold in the United States. 6  
In general, high myopia is bilateral and associated with multiple ocular morbidities such as cataract, glaucoma, and retinal detachment. 13 One of the most important complications is myopic maculopathy, which is a common cause of visual impairment. 12 Myopic maculopathy is defined as the presence of a spectrum of signs including lacquer cracks, posterior staphyloma, patchy atrophy, choridal neovascularization, and geographic atrophy. 14 Because of its earlier onset in the working age population, the expected person-years of blindness for people with myopic maculopathy are 7 years more than for those with glaucoma and 12 years more than for those with diabetic retinopathy or age-related macular degeneration. 15,16 The magnitude of public health impact of myopia-related vision loss is therefore substantial. 
However, despite its importance, there are few population-based epidemiological studies of the myopic maculopathy. The purpose of this study was to determine the prevalence and associated risk factors of myopic maculopathy in an elderly Chinese population in Taiwan. 
Materials and Methods
Populations and Procedures
The study population and methodology in the Shihpai Eye Study have been described elsewhere. 17 The acquisition and grading of fundus photographs have also been reported. 18 In brief, residents 65 years of age and older in Shihpai, Taipei, Taiwan, were identified from the household registration databank provided by the Household Registration Office. Of the 2045 randomly selected individuals, 1361 (66.6%) participated in the ophthalmic examination. Of the participants, 1105 had photographs taken and 1058 had gradable photographs in at least one eye. Subjects (n = 303) who had no photos or gradable photos in both eyes were older and more likely to have denser lens opacity. 18  
A structured questionnaire was used to collect information on basic demographic data, education, and medical history. The ophthalmic examinations included measurements of visual acuity with Snellen charts at a distance of 6 m, autorefraction (RK-8100; Topcon, Tokyo, Japan), noncontact tonometry (CT-60; Topcon), slit-lamp biomicroscopy (Model BQ900; Haag-Streit, Bern, Switzerland), and indirect ophthalmoscopy (Model 12500; Skaneateles Falls, NY) through a dilated pupil with 1% tropicamide (Alcon, Couvreur, Puurs, Belgium). Lens opacity was graded using slit lamp biomicroscopy with the modified Lens Opacity Classification System (LOCS) III. 19 In addition, ultrasound biometry (AL-1000, Tomey Corporation, Aichi, Japan) was performed for those with pseudophakia or aphakia. Informed consent was obtained from each subject before his or her enrollment in the study. This study was conducted according to the tenets of the Declaration of Helsinki and approved by the institutional review board in Taipei Veterans General Hospital. 
Both eyes of the participants were photographed using a 35° monoscopic fundus camera (TRC-50IA; Topcon) at least 30 minutes after pupil dilatation. Two photography fields were taken in each eye, with one centered at the fovea and the other at the optic disc. Blood pressure was measured from the right arm, with the participant in a seated position using manual sphygmomanometer, for three times at least 5 minutes apart. The average of the three measurements were used for analysis. Body height and weight were measured and the body mass index (BMI) was calculated. 
Definitions
High myopia was defined as a spherical equivalent of less than −6.0 D in the phakic eyes, low to moderate myopia as a spherical equivalent of −0.5 to −5.9 D, and no myopia as a spherical equivalent of greater than −0.5. In participants with pseudophakia or aphakia, high myopia was defined if axial length was greater than 26.5 mm. 7,8 The grade of myopia was defined according the more severely affected eye for each participant. The grading of myopic maculopathy was done by a retinal specialist (SJC) based on fundus photographs (Fig. 1) and myopic maculopathy was categorized according to the Avilla's grading method 14 : M0, normal appearing posterior pole; M1, tessellation and choroidal pallor pattern in macular area; M2, appearance of a posterior staphyloma; M3, yellowish lacquer cracks in Bruch's membrane; M4, focal areas of deep choroidal atrophy secondary to lacquer cracks or posterior staphyloma; and M5, geographic areas of atrophy of retinal pigment epithelium and choroids, and choroidal neovascularization (CNV; active CNV or fibrosis, or Fuchs' spot). This grading system with step-wise severity level of maculopathy has been shown to be functionally correlated with greater visual impairment in more severe grading after long-term follow-up. 8 In addition, more than 50% of patients with high myopic retinopathy of lacquer cracks alone would lose their vision after 10 years. 8 Therefore, we defined those with maculopathy equal to or greater than M3 as clinically significant myopic maculopathy in this study. When two eyes of a participant were discrepant for the severity of myopic maculopathy, the grade assigned for the participant was that of the more severe eye. Other retinal pathology, such as age-related macular degeneration, epiretinal membrane, or previous retinal detachment surgery, was excluded. 
Figure 1. 
 
Grading examples of the fundus photographs of myopic maculopathy. M0, normal appearing posterior pole; M1, tessellation and choroidal pallor pattern in macular area; M2, appearance of border of a posterior staphyloma (arrows) near disc area; M3, yellowish lacquer cracks in Bruch's membrane (arrow); M4, focal areas of deep choroidal atrophy (arrow); and M5, geographic areas of atrophy of retinal pigment epithelium and choroids (lower arrow), or evidence of choroidal neovascularization in active stage or with fibrosis (upper arrow).
Figure 1. 
 
Grading examples of the fundus photographs of myopic maculopathy. M0, normal appearing posterior pole; M1, tessellation and choroidal pallor pattern in macular area; M2, appearance of border of a posterior staphyloma (arrows) near disc area; M3, yellowish lacquer cracks in Bruch's membrane (arrow); M4, focal areas of deep choroidal atrophy (arrow); and M5, geographic areas of atrophy of retinal pigment epithelium and choroids (lower arrow), or evidence of choroidal neovascularization in active stage or with fibrosis (upper arrow).
Statistical Analysis
The prevalence of high myopia and myopic maculopathy by age group and sex was expressed in percentages of the study population. The χ2 test was used for evaluating the trend of prevalence in age groups. The associations of myopic maculopathy with age, sex, education, cigarette smoking, alcohol drinking, BMI, self-reported diabetes, systolic and diastolic blood pressure, and taking anti-hypertension medication were assessed. Multivariate logistic regression analysis was used to obtain adjusted odds ratios (OR) of having myopic maculopathy, allowing for controls of the mutually confounding effects of these potential risk factors. All data analyses were performed using a commercial statistical software package, SPSS 17.0 (Chicago, IL). 
Results
There were 44 (4.2%) subjects with high myopia among the 1058 participants with gradable retinal photographs. Twelve high myopics had no myopic maculopathy (three in grade M0, five in grade M1, and four in grade M2). A total of 32 participants (7 in grade M3, 8 in grade M4, and 17 in grade M5) had myopic maculopathy equal to or greater than stage M3, corresponding to a prevalence of 3.0% (95% confidence interval, 2.1%–4.2%). Table 1 presents the distribution of no myopia, low to moderate myopia, and high myopia by sex and age groups. There was an age-related trend in the prevalence of high myopia (P = 0.003) and low and moderate myopia (P < 0.001). Table 2 presents the status of myopic maculopathy in the high myopics. In subjects with high myopia, there was a significant age trend for myopic maculopathy (P = 0.004), in particular in women (P = 0.028). 
Table 1. 
 
Prevalence of No Myopia, Low and Moderate Myopia, and High Myopia by Age and Sex
Table 1. 
 
Prevalence of No Myopia, Low and Moderate Myopia, and High Myopia by Age and Sex
Age Groups, y n No Myopia Low and Moderate Myopia High Myopia
Men Women Total Men Women Total Men Women Total
n %* n %* n %† n %* n %* n %† n %* n %* n %†
65–69 403 189 77.1 115 72.3 304 75.4 50 20.4 36 22.8 86 21.3 6 2.4 7 4.4 13 3.2
70–74 389 180 69.0 94 73.4 274 70.4 72 27.6 30 23.4 102 26.2 9 3.4 4 3.1 13 3.3
75–79 188 63 62.4 51 58.6 114 60.9 35 34.7 29 33.3 64 34.0 3 3.0 7 8.0 10 5.3
80-84 51 17 56.7 10 47.6 27 52.9 11 36.7 10 47.6 21 41.2 2 6.7 1 4.8 3 5.9
85+ 27 13 61.9 0 0 13 48.2 5 23.8 4 66.7 9 33.3 3 14.3 2 33.3 5 18.5
P 0.001 <0.001 <0.001 0.023 0.002 <0.001 0.022 0.05 0.003
Table 2. 
 
High Myopia by Maculopathy Status*
Table 2. 
 
High Myopia by Maculopathy Status*
Age Groups, y n Maculopathy <M3 MaculopathyM3
Men Women Total Men Women Total
n %† n %† n %‡ n %† n %† n %‡
65–69 403 1 0.4 3 1.9 4 1.0 5 2.0 4 2.5 9 2.2
70–74 389 3 1.1 1 0.8 4 1.0 6 2.3 3 2.3 9 2.3
75–79 188 2 2.0 0 0 2 1.1 1 1.0 7 8.1 8 4.3
80–84 51 1 3.3 0 0 1 2.0 1 3.3 1 4.8 2 3.9
85+ 27 0 0 1 16.7 1 3.7 3 14.3 1 33.3 4 14.8
Total 1058 7 1.1 5 1.3 12 1.1 16 2.4 16 4.3 32 3.0
P 0.061 0.642 0.090 0.057 0.028 0.004
Among the 44 subjects with high myopia, 9 (20.5%) had bilateral myopic maculopathy, 23 (52.3%) had unilateral myopic maculopathy, 2 (4.5%) had bilateral high myopia without myopic maculopathy, and 10 (22.7%) had unilateral high myopia without myopic maculopathy. There were a total of 65 eyes with high myopia. The average best-corrected logMAR visual acuity by grade was 0.29 in M0 (number of the eyes, n = 4), 0.33 in M1 (n = 11), 0.18 in M2 (n = 9), 0.39 in M3 (n = 12), 0.37 in M4 (n = 12), and 1.1 in M5 (n = 17). Of them, eyes with maculopathy had worse corrected visual acuity (logMAR, 0.72 ± 0.6), compared to eyes without maculopathy (0.27 ± 0.2, P = 0.001; Table 3). Of the 31 phakic eyes, eyes with myopic maculopathy were associated with more myopic degree than those without (−12.8 ± 5.1 D vs. −7.6 ± 1.5 D, P = 0.001). Of the 34 pseudophakic or aphakic eyes, the axial length was not significantly different between the two groups (28.0 ± 1.9 mm vs. 27.1 ± 0.5 mm, P = 0.072). The percentage of eyes with lens opacity or eyes that had undergone cataract surgery was not different between the two groups (Table 3). 
Table 3. 
 
Ocular Characteristics in High Myopic Eyes with or without Maculopathy
Table 3. 
 
Ocular Characteristics in High Myopic Eyes with or without Maculopathy
Without Maculopathy (n = 24) With Maculopathy (n = 41) P
Best corrected visual acuity in logMAR 0.27 ± 0.2 0.72 ± 0.6 0.001
Pseudophakia or aphakia (%) 15 (63%) 19 (46%) 0.304
Spherical equivalent (D)* −7.6 ± 1.5 −12.8 ± 5.1 0.001
Axial length (mm)† 27.1 ± 0.5 28.0 ± 1.9 0.072
Cataract (%)‡ 18 (75%) 35 (85%) 0.335
Univariate analysis suggested that systolic blood pressure (SBP) was significantly higher in the high myopics with maculopathy (146.4 ± 16.2 mm Hg) than those without (127.0 ± 15.9 mm Hg, P = 0.001; Table 4). The difference remained significant (P = 0.02) after further adjustment for age, sex, diastolic blood pressure, smoking, educational level, BMI, alcohol drinking, history of diabetes, and history of taking anti-hypertension medication; for each 10 mm Hg increase in SBP, the OR of having myopic maculopathy was 2.46 (95% CI: 1.66–3.64, P = 0.02). SBP was also significantly higher in subjects with myopic maculopathy, compared with those with low or moderate myopia (P = 0.002; Fig. 2). 
Figure 2. 
 
Systolic blood pressure in low and moderate myopia, high myopia without maculopathy, and high myopia with maculopathy.
Figure 2. 
 
Systolic blood pressure in low and moderate myopia, high myopia without maculopathy, and high myopia with maculopathy.
Table 4. 
 
Factors Associated with High Myopic Subjects with or without Maculopathy
Table 4. 
 
Factors Associated with High Myopic Subjects with or without Maculopathy
Without Maculopathy (n = 12) With Maculopathy (n = 32) P
Age (y) 73.3 ± 6.1 74.3 ± 6.6 0.658
Sex (men, %) 58% 50% 0.622
Education (higher than junior high school, %) 58.3% 46.9% 0.498
Diabetes (%) 16.7% 15.6% 0.933
Smoking (current, %) 25.0% 37.5% 0.436
Alcohol drinking (current, %) 8.3% 0% 0.099
Taking anti-hypertension medication (%) 41.7% 34.4% 0.654
Systolic blood pressure (mm Hg) 127.0 ± 15.9 146.4 ± 16.2 0.001
Diastolic blood pressure (mm Hg) 73.8 ± 10.1 77.8 ± 10.5 0.260
BMI (kg/m2) 24.0 ± 3.9 24.9 ± 3.4 0.499
Discussion
In this elderly Chinese population in Taiwan, the prevalence of myopic maculopathy was 3.0%, which was similar to that in Beijing Eye Study (BES) (3.1%), 20 but higher than the Blue Mountains Eye Study (BMES) (1.2%). 21 However, direct comparisons may be difficult for several reasons. First, these studies defined myopic maculopathy based on fundus findings without the criteria of refractive error, which may be prone to misclassification. Second, posterior staphyloma was one of the criteria of myopia maculopathy in the other studies but not ours. Finally, our study population (≥65 years) was older than the two studies (≥49 years in BMES and >40 years in BES) (Table 5). 
Table 5. 
 
Prevalence of Myopic Retinopathy in Different Population-Based Studies
Table 5. 
 
Prevalence of Myopic Retinopathy in Different Population-Based Studies
Blue Mountains 2002 Beijing 2010 Present Study
Population (age, n) ≥49 y; 3654 ≥40 y; 4319 ≥65 y; 1361
Definition Staphyloma Staphyloma SE ≤ −6.0 D or axial length ≥ 26.5 mm
Lacquer cracks Lacquer cracks Lacquer cracks
Fuchs' spot Fuchs' spot Fuchs' spot
Chorioretinal atrophy Chorioretinal atrophy Chorioretinal atrophy
Mean SE (D) −6.1 −8.9 −12.8
Mean visual acuity (Snellen) 20/40 20/36 20/105
Prevalence 1.2% 3.1% 3.0%
In our study, the definition of refractive error or axial length was a prerequisite for myopic maculopathy cases. The reason for this approach is that we felt it increased the specificity for myopia-related maculopathy and diminished the issue in subjects with ambiguous fundus findings, and thus reduced ascertainment bias. If we included refractive criteria (<−6.0 D) to the above two studies and included posterior staphyloma as a criteria of myopic maculopathy in our study, the proportion of myopic maculopathy in high myopic eyes in our study (73%, 47/65 eyes) is higher than in the BES (65%, 140/214 eyes) and much higher than in the BMES (25%, 20/79 subjects). Thus, our study suggests that the higher prevalence of myopic maculopathy and higher proportion of maculopathy among the high myopic eyes in the Chinese people might imply a racial difference between Chinese and whites. 
As discussed, difference in age may account in part for the higher prevalence of myopia maculopathy in our study. Aging has an impact on the anatomical and functional outcomes in patients with myopic maculopathy. Clinic-based studies have shown that increased severity of maculopathy is associated with increased axial length as well as increased age. 8,22 With aging, the lacquer cracks extend and thus increase the areas of choriocapillary atrophy as well as the chances of CNV ingrowths from ruptured Bruch's membrane. 23 More than half of the patients with lacquer cracks had progression in numbers and severity in an average follow-up after 6 or 12 years. 23,24 The lacquer crack is an initiating factor of subsequent degeneration of retina and CNV development in high myopia. 25 Lacquer cracks are thus the precursor and hallmark of high myopic maculopathy. Because of their prominent and distinct clinical features as well as their prognostic implication, we suggest that lacquer cracks be an important clinical sign in future epidemiological studies. In screening high myopic subjects, appearance of lacquer cracks denotes more frequent future follow-ups in preventing myopic blindness, provided that effective treatment for high myopic CNV is available. 
Our study also showed that the modifiable factor of SBP may play a role in high myopic subjects with maculopathy. In our study, for every 10 mm Hg increase in SBP, the odds of acquiring maculopathy were 150% greater in high myopic patients after adjustment for age, taking anti-hypertensive medication, and other potential confounders. Most of all, subjects with the most severe maculopathy of CNV or geographic atrophy had a higher SBP than subjects with other less severe stages. The reason was not clear in this cross-sectional study, although increased SBP has been reported to be associated with exudative AMD. 26,27 Recent studies on the diurnal variation of choroidal thickness in normal subjects showed that SBP played a significant role on the thickness change. 28,29 Higher SBP was associated with thinner choroidal thickness in the afternoon. 29 The high SBP in myopic patients may further compromise the already thinner choroid, 30 hamper the choroidal circulation, and hence increase the severity of maculopathy. Our finding of SBP as a risk factor needs further verification in longitudinal cohort studies. Furthermore, it is still unknown if this finding applies to younger populations. Future interventional studies or clinical studies might consider including blood pressure measurement for analysis. 
Our study was limited in several aspects. The 66.6% participation rate is lower than other studies with a younger population. 17 Yet the rate is comparable to other aged population surveys. 31 The participants with gradable photographs were younger than those nonparticipants or participants with ungradable photographs. However, the difference was small. 18 There were two definitions of high myopia in our study, as for aphakic or pseudophakic eyes, but we were unable to acquire data of their spherical equivalent before cataract surgery. For aphakic or pseudophakic eyes, we used a more or less strict definition for high myopia (axial length ≥26.5 mm), thus the prevalence of high myopia might have been underestimated to some extent. However, we believe the effect of including the axial length as a defining characteristic in the prevalence of myopic maculopathy is minimal if any. There is no consensus on the cutoff value of axial length for high myopia at present. 13 This cutoff was adopted in several studies as the definition of high myopia. 8,32 Furthermore, studies showed that there were significantly more retinal complications in eyes with axial length longer than 26.5 mm. 7,33 Our findings of association between SBP and myopia maculopathy is also limited by the study's small sample and the cross-sectional design. Further studies such as case–control studies are needed to compare the SBP measured in the clinic and monitored at home as well as its relationship with myopic maculopathy. 
In conclusion, high myopic maculopathy with lacquer cracks, focal or geographic chorioretinal atrophy, and Fuchs' spot was present in 3.0% of the elderly Chinese people in Shihpai area in Taiwan. It was associated with higher SBP. Eyes with maculopathy were associated with greater myopic degree and lower visual acuity. The association of high SBP and myopic maculopathy needs further verification from other studies with long-term follow-up. 
Acknowledgments
The authors thank Dr. Tien-Yin Wong for critical reviewing the manuscript. 
References
Cheng CY Hsu WM Liu JH Tsai SY Chou P. Refractive errors in an elderly Chinese population in Taiwan: the Shihpai Eye Study. Invest Ophthalmol Vis Sci . 2003;44:4630–4638. [CrossRef] [PubMed]
Lin LL Shih YF Hsiao CK Chen CJ. Prevalence of myopia in Taiwanese schoolchildren: 1983 to 2000. Ann Acad Med Singapore . 2004;33:27–33. [PubMed]
Saw SM Katz J Schein OD Chew SJ Chan TK. Epidemiology of myopia. Epidemiol Rev . 1996;18:175–187. [CrossRef] [PubMed]
Sperduto RD Seigel D Roberts J Rowland M. Prevalence of myopia in the United States. Arch Ophthalmol . 1983;101:405–407. [CrossRef] [PubMed]
Bar Dayan Y Levin A Morad Y The changing prevalence of myopia in young adults: a 13-year series of population-based prevalence surveys. Invest Ophthalmol Visual Sci . 2005;46:2760–2765. [CrossRef]
Vitale S Sperduto RD Ferris FL 3rd. Increased prevalence of myopia in the United States between 1971-1972 and 1999-2004. Arch Ophthalmol . 2009;127:1632–1639. [CrossRef] [PubMed]
Percival SP. Redefinition of high myopia: the relationship of axial length measurement to myopic pathology and its relevance to cataract surgery. Dev Ophthalmol . 1987;14:42–46. [PubMed]
Shih YF Ho TC Hsiao CK Lin LL. Visual outcomes for high myopic patients with or without myopic maculopathy: a 10 year follow up study. Br J Ophthalmol . 2006;90:546–550. [CrossRef] [PubMed]
Liu JH Cheng CY Chen SJ Lee FL. Visual impairment in a Taiwanese population: prevalence, causes, and socioeconomic factors. Ophthalmic Epidemiol . 2001;8:339–350. [PubMed]
Xu L Li J Cui T Refractive error in urban and rural adult Chinese in Beijing. Ophthalmology . 2005;112:1676–1683. [CrossRef] [PubMed]
Raju P Ramesh SV Arvind H Prevalence of refractive errors in a rural South Indian population. Invest Ophthalmol Vis Sci . 2004;45:4268–4272. [CrossRef] [PubMed]
Chan WM Ohji M Lai TY Liu DT Tano Y Lam DS. Choroidal neovascularisation in pathological myopia: an update in management. Br J Ophthalmol . 2005;89:1522–1528. [CrossRef] [PubMed]
Saw SM Gazzard G Shih-Yen EC Chua WH. Myopia and associated pathological complications. Ophthalmic Physiol Opt . 2005;25:381–391. [CrossRef] [PubMed]
Avila MP Weiter JJ Jalkh AE Trempe CL Pruett RC Schepens CL. Natural history of choroidal neovascularization in degenerative myopia. Ophthalmology . 1984;91:1573–1581. [CrossRef] [PubMed]
Green JS Bear JC Johnson GJ. The burden of genetically determined eye disease. Br J Ophthalmol . 1986;70:696–699. [CrossRef] [PubMed]
Steidl SM. How does visual acuity change over time in adults with high myopia? Br J Ophthalmol . 2006;90:524. [CrossRef] [PubMed]
Hsu WM Cheng CY Liu JH Tsai SY Chou P. Prevalence and causes of visual impairment in an elderly Chinese population in Taiwan: The Shihpai Eye Study. Ophthalmology . 2004;111:62–69. [CrossRef] [PubMed]
Chen SJ Cheng CY Peng KL Prevalence and associated risk factors of age-related macular degeneration in an elderly Chinese population in Taiwan: The Shihpai Eye Study. Invest Ophthalmol Vis Sci . 2008;49:3126–3133. [CrossRef] [PubMed]
Chylack LT Jr Wolfe JK Singer DM The Lens Opacities Classification System III. The Longitudinal Study of Cataract Study Group. Arch Ophthalmol . 1993;111:831–836. [CrossRef] [PubMed]
Liu HH Xu L Wang YX Wang S You QS Jonas JB. Prevalence and progression of myopic retinopathy in Chinese adults: The Beijing Eye Study. Ophthalmology . 2010;117:1763–1768. [CrossRef] [PubMed]
Vongphanit J Mitchell P Wang JJ. Prevalence and progression of myopic retinopathy in an older population. Ophthalmology . 2002;109:704–711. [CrossRef] [PubMed]
Saka N Ohno-Matsui K Shimada N Long-term changes in axial length in adult eyes with pathologic myopia. Am J Ophthalmol . 2010;150:562–568. e1. [CrossRef] [PubMed]
Ohno-Matsui K Tokoro T. The progression of lacquer cracks in pathologic myopia. Retina . 1996;16:29–37. [PubMed]
Hayashi K Ohno-Matsui K Shimada N Long-term pattern of progression of myopic maculopathy: a natural history study. Ophthalmology . 2010;117:1595–1611. 1611.e1-4. [CrossRef] [PubMed]
Ohno-Matsui K Yoshida T Futagami S Patchy atrophy and lacquer cracks predispose to the development of choroidal neovascularisation in pathological myopia. Br J Ophthalmol . 2003;87:570–573. [CrossRef] [PubMed]
Klein R Klein BE Tomany SC Cruickshanks KJ. The association of cardiovascular disease with the long-term incidence of age-related maculopathy: The Beaver Dam Eye Study. Ophthalmology . 2003;110:1273–1280. [CrossRef] [PubMed]
van Leeuwen R Ikram MK Vingerling JR Witteman JC Hofman A de Jong PT. Blood pressure, atherosclerosis, and the incidence of age-related maculopathy: the Rotterdam Study. Invest Ophthalmol Vis Sci . 2003;44:3771–3777. [CrossRef] [PubMed]
Tan CS Ouyang Y Ruiz H Sadda SR. Diurnal variation of choroidal thickness in normal, healthy subjects measured by spectral domain optical coherence tomography. Invest Ophthalmol Vis Sci . 2012;53:261–266. [CrossRef] [PubMed]
Usui S Ikuno Y Akiba M Circadian changes in subfoveal choroidal thickness and the relationship with circulatory factors in healthy subjects. Invest Ophthalmol Vis Sci . 2012;53:2300–2307. [CrossRef] [PubMed]
Wang NK Lai CC Chu HY Classification of early dry-type myopic maculopathy with macular choroidal thickness. Am J Ophthalmol . 2012;153:669–677. 677.e1-2. [CrossRef] [PubMed]
Munoz B West SK Rubin GS Causes of blindness and visual impairment in a population of older Americans: The Salisbury Eye Evaluation Study. Arch Ophthalmol . 2000;118:819–825. [CrossRef] [PubMed]
Jonas JB Berenshtein E Holbach L. Lamina cribrosa thickness and spatial relationships between intraocular space and cerebrospinal fluid space in highly myopic eyes. Invest Ophthalmol Vis Sci . 2004;45:2660–2665. [CrossRef] [PubMed]
Curtin BJ Karlin DB. Axial length measurements and fundus changes of the myopic eye. I. The posterior fundus. Trans Am Ophthalmol Soc . 1970;68:312–334. [PubMed]
Footnotes
 Presented in part at the Annual Meeting of the Association for Research in Vision and Ophthalmology, Fort Lauderdale, FL, May 2010.
Footnotes
 Supported by grants from Taipei Veterans General Hospital (VGH 89-404).
Footnotes
 Disclosure: S.-J. Chen, None; C.-Y. Cheng, None; A.-F. Li, None; K.-L. Peng, None; P. Chou, None; S.-H. Chiou, None; W.-M. Hsu, None
Figure 1. 
 
Grading examples of the fundus photographs of myopic maculopathy. M0, normal appearing posterior pole; M1, tessellation and choroidal pallor pattern in macular area; M2, appearance of border of a posterior staphyloma (arrows) near disc area; M3, yellowish lacquer cracks in Bruch's membrane (arrow); M4, focal areas of deep choroidal atrophy (arrow); and M5, geographic areas of atrophy of retinal pigment epithelium and choroids (lower arrow), or evidence of choroidal neovascularization in active stage or with fibrosis (upper arrow).
Figure 1. 
 
Grading examples of the fundus photographs of myopic maculopathy. M0, normal appearing posterior pole; M1, tessellation and choroidal pallor pattern in macular area; M2, appearance of border of a posterior staphyloma (arrows) near disc area; M3, yellowish lacquer cracks in Bruch's membrane (arrow); M4, focal areas of deep choroidal atrophy (arrow); and M5, geographic areas of atrophy of retinal pigment epithelium and choroids (lower arrow), or evidence of choroidal neovascularization in active stage or with fibrosis (upper arrow).
Figure 2. 
 
Systolic blood pressure in low and moderate myopia, high myopia without maculopathy, and high myopia with maculopathy.
Figure 2. 
 
Systolic blood pressure in low and moderate myopia, high myopia without maculopathy, and high myopia with maculopathy.
Table 1. 
 
Prevalence of No Myopia, Low and Moderate Myopia, and High Myopia by Age and Sex
Table 1. 
 
Prevalence of No Myopia, Low and Moderate Myopia, and High Myopia by Age and Sex
Age Groups, y n No Myopia Low and Moderate Myopia High Myopia
Men Women Total Men Women Total Men Women Total
n %* n %* n %† n %* n %* n %† n %* n %* n %†
65–69 403 189 77.1 115 72.3 304 75.4 50 20.4 36 22.8 86 21.3 6 2.4 7 4.4 13 3.2
70–74 389 180 69.0 94 73.4 274 70.4 72 27.6 30 23.4 102 26.2 9 3.4 4 3.1 13 3.3
75–79 188 63 62.4 51 58.6 114 60.9 35 34.7 29 33.3 64 34.0 3 3.0 7 8.0 10 5.3
80-84 51 17 56.7 10 47.6 27 52.9 11 36.7 10 47.6 21 41.2 2 6.7 1 4.8 3 5.9
85+ 27 13 61.9 0 0 13 48.2 5 23.8 4 66.7 9 33.3 3 14.3 2 33.3 5 18.5
P 0.001 <0.001 <0.001 0.023 0.002 <0.001 0.022 0.05 0.003
Table 2. 
 
High Myopia by Maculopathy Status*
Table 2. 
 
High Myopia by Maculopathy Status*
Age Groups, y n Maculopathy <M3 MaculopathyM3
Men Women Total Men Women Total
n %† n %† n %‡ n %† n %† n %‡
65–69 403 1 0.4 3 1.9 4 1.0 5 2.0 4 2.5 9 2.2
70–74 389 3 1.1 1 0.8 4 1.0 6 2.3 3 2.3 9 2.3
75–79 188 2 2.0 0 0 2 1.1 1 1.0 7 8.1 8 4.3
80–84 51 1 3.3 0 0 1 2.0 1 3.3 1 4.8 2 3.9
85+ 27 0 0 1 16.7 1 3.7 3 14.3 1 33.3 4 14.8
Total 1058 7 1.1 5 1.3 12 1.1 16 2.4 16 4.3 32 3.0
P 0.061 0.642 0.090 0.057 0.028 0.004
Table 3. 
 
Ocular Characteristics in High Myopic Eyes with or without Maculopathy
Table 3. 
 
Ocular Characteristics in High Myopic Eyes with or without Maculopathy
Without Maculopathy (n = 24) With Maculopathy (n = 41) P
Best corrected visual acuity in logMAR 0.27 ± 0.2 0.72 ± 0.6 0.001
Pseudophakia or aphakia (%) 15 (63%) 19 (46%) 0.304
Spherical equivalent (D)* −7.6 ± 1.5 −12.8 ± 5.1 0.001
Axial length (mm)† 27.1 ± 0.5 28.0 ± 1.9 0.072
Cataract (%)‡ 18 (75%) 35 (85%) 0.335
Table 4. 
 
Factors Associated with High Myopic Subjects with or without Maculopathy
Table 4. 
 
Factors Associated with High Myopic Subjects with or without Maculopathy
Without Maculopathy (n = 12) With Maculopathy (n = 32) P
Age (y) 73.3 ± 6.1 74.3 ± 6.6 0.658
Sex (men, %) 58% 50% 0.622
Education (higher than junior high school, %) 58.3% 46.9% 0.498
Diabetes (%) 16.7% 15.6% 0.933
Smoking (current, %) 25.0% 37.5% 0.436
Alcohol drinking (current, %) 8.3% 0% 0.099
Taking anti-hypertension medication (%) 41.7% 34.4% 0.654
Systolic blood pressure (mm Hg) 127.0 ± 15.9 146.4 ± 16.2 0.001
Diastolic blood pressure (mm Hg) 73.8 ± 10.1 77.8 ± 10.5 0.260
BMI (kg/m2) 24.0 ± 3.9 24.9 ± 3.4 0.499
Table 5. 
 
Prevalence of Myopic Retinopathy in Different Population-Based Studies
Table 5. 
 
Prevalence of Myopic Retinopathy in Different Population-Based Studies
Blue Mountains 2002 Beijing 2010 Present Study
Population (age, n) ≥49 y; 3654 ≥40 y; 4319 ≥65 y; 1361
Definition Staphyloma Staphyloma SE ≤ −6.0 D or axial length ≥ 26.5 mm
Lacquer cracks Lacquer cracks Lacquer cracks
Fuchs' spot Fuchs' spot Fuchs' spot
Chorioretinal atrophy Chorioretinal atrophy Chorioretinal atrophy
Mean SE (D) −6.1 −8.9 −12.8
Mean visual acuity (Snellen) 20/40 20/36 20/105
Prevalence 1.2% 3.1% 3.0%
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×